Skip to main content

Advertisement

SpringerLink
Log in

Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Nephrogenic systemic fibrosis (NSF) is a disease characterized by fibrosis of the systemic organs in patients with renal failure. Following the findings of recent epidemiological studies and the finding of gadolinium (Gd) in the skin tissue of NSF patients, it is now definitely known that the use of Gd contrast agents can trigger NSF. To date, however, the exact mechanism underlying the induction of fibrosis in various organs by Gd remains unexplained. This study was undertaken to evaluate the influence of Gd on the proliferation activity and collagen production of cultured fibroblasts. Normal human dermis-derived fibroblasts were incubated in the presence of gadodiamide (GA) in the concentration range of 5 × 10−7 to 5 × 10−3 M. The proliferation activity of the cells was assessed on the basis of the cell counts in the fibroblast growth curve and the DNA-synthetic activity of the cells (indicator; level of 3H-thymidine uptake by cells). The collagen production was evaluated by densitometric measurement of the quantity of collagen through electrophoresis and fluorography after incorporation of 3H-proline into the procollagens. Furthermore, the expression levels of the genes for type I and III collagen were measured by real-time reverse transcription polymerase chain reaction (RT-PCR) assay. The cell count tended to be higher when the fibroblasts were incubated in medium containing GA in the concentration range of 5 × 10−7 to 5 × 10−4M as compared to that in the GA-free control cultures; furthermore, the DNA-synthetic activity also rose in a concentration-dependent manner in the GA-treated group as compared to that in the control group. No significant changes in either the collagen production or the collagen gene expression levels were noted in cultures containing GA at concentrations between 5 × 10−7 and 5 × 10−3 M. These results suggest that the formation of sclerosing lesions in patients with NSF may be attributable to the effect of GA of enhancing the growth activity of fibroblasts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Brazova L, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A (2006) Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin Immunol 121:350–357

    Article  CAS  PubMed  Google Scholar 

  2. Broome DR (2008) Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66:230–234

    Article  PubMed  Google Scholar 

  3. Bujor MA, Pannu J, Bu S, Smith AE, Muise-Helmericks CR, Trojanowska M (2008) Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 128:1906–1914

    Article  CAS  PubMed  Google Scholar 

  4. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001

    Article  CAS  PubMed  Google Scholar 

  5. Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O’Brien PE (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39:967–971

    Article  CAS  PubMed  Google Scholar 

  6. Do C, Barnes JL, Tan C, Wagner B (2014) Type of mri contrast, tissue gadolinium, and fibrosis. Am J Physiol Renal Physiol 307:F844–F855

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Edward M, Quinn JA, Mukherjee S, Jensen MB, Jardine AG, Mark PB, Burden AD (2008) Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214:584–593

    Article  CAS  PubMed  Google Scholar 

  8. Fleischmajer R, Perlish JS, Krieg T, Timpl R (1981) Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 76:400–403

    Article  CAS  PubMed  Google Scholar 

  9. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316:83–94

    Article  CAS  PubMed  Google Scholar 

  10. Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2 (I) collagen genes in a patient with a pro alpha 2 (I)–chain–defective variant of Ehlers-Danlos syndrome. Eur J Biochem 174:231–237

    Article  CAS  PubMed  Google Scholar 

  11. Hatamochi A, Arakawa M, Takeda K, Ueki H (1994) Activation of fibroblast proliferation by Werner’s syndrome fibroblast-conditioned medium. J Dermatol Sci 7:210–216

    Article  CAS  PubMed  Google Scholar 

  12. Hayashi S, Ikeda M, Kitamura Y, Hamasaki Y, Hatamochi A (2012) UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. J Dermatol Sci 67:20–25

    Article  CAS  PubMed  Google Scholar 

  13. Helmig S, Belwe A, Schneider J (2009) Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. J Investig Med 57:655–661

    Article  CAS  PubMed  Google Scholar 

  14. High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2006) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21–26

    Article  PubMed  Google Scholar 

  15. Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC (2004) Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 50:2660–2666

    Article  CAS  PubMed  Google Scholar 

  16. Kay J (2008) Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction. Ann Rheum Dis 67(suppl 3):66–69

    Google Scholar 

  17. Koreishi AF, Nazarian RM, Saenz AJ, Klepeis VE, McDonald AG, Farris AB, Colvin RB, Duncan LM, Mandal RV, Kay J (2009) Nephrogenic systemic fibrosis: a pathologic study of autopsy cases. Arch Pathol Lab Med 133:1943–1948

    PubMed  Google Scholar 

  18. Le LP, Garibyan L, Lara D, Finberg KE, Lafrate AJ, Duncan LM, Kay J, Nazarian RM (2013) Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosis. Am J Dermatopathol 35:351–356

    Article  PubMed  Google Scholar 

  19. Morcos SK, Thomsen HS (2008) Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 110:24–31

    Article  Google Scholar 

  20. Namikawa H, Sunazuka T, Kitamura Y, Suzuki T, Hamasaki Y, Yamazaki S, Omura S, Hatamochi A (2010) Effect of erythromycin A and its new derivative EM201 on type I collagen production by cultured dermal fibroblasts. Arch Dermatol Res 302:341–348

    Article  CAS  PubMed  Google Scholar 

  21. Quatresooz P, Paquet P, Hermanns-Lê T, Piérard GE (2010) Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis. Appl Immunohistochem Mol Morphol 18:448–452

    CAS  PubMed  Google Scholar 

  22. Reyes-Gordillo K, Shah R, Arellanes-Robledo J, Hemandez-Nazara Z, Rincon-Sanchez RA, Inagaki Y, Rojkind M, Raj Lakshman M (2014) Mechanisms of action of acetaldehyde in the Up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7. Am J Pathol 184:1458–1467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Shah M, Revis D, Herrick S, Baillie R, Thorgeirson S, Ferguson M, Roberts A (1999) Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol 154:1115–1124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Todd DJ, Kagan A, Chibnik LB, Kay J (2007) Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Arthritis Rheum 56:3433–3441

    Article  PubMed  Google Scholar 

  25. Wagner B, Tan C, Barnes JL, Ahuja S, Davis TL, Gorin Y, Jimenez F (2012) Nephrogenic systemic fibrosis: evidence for oxidative stress and bone marrow-derived fibrocytes in skin, liver, and heart lesions using a 5/6 nephrectomy rodent model. Am J Pathol 181:1941–1952

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Dokkyo Medical University, School of Medicine, Mibu, Tochigi, Japan

    Yumi Ozawa, Shujiro Hayashi, Yoichiro Hamasaki & Atsushi Hatamochi

Authors
  1. Yumi Ozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shujiro Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoichiro Hamasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Atsushi Hatamochi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shujiro Hayashi.

Ethics declarations

Conflict of interest

The authors state no conflicts of interest. Authors also observed the protocol approved by the Institutional Review Board of Dokkyo Medical University Hospital (ID: 1706).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozawa, Y., Hayashi, S., Hamasaki, Y. et al. Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts. Arch Dermatol Res 308, 695–701 (2016). https://doi.org/10.1007/s00403-016-1689-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-016-1689-9

Keywords

Search

Navigation